February 5, 2024

Procyrion Closes $57.7 Million in Series E Financing

Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the completion of a $57.7 million Series E funding round, including the conversion of $10.0 million of interim financing.

Read More
Older Posts